Comments on: Cell Genesys halts VITAL-2 GVAX trial http://prostatecancerinfolink.net/2008/08/27/cell-genesys-halts-vital-2-gvax-trial/ Sun, 12 Feb 2012 22:40:37 +0000 hourly 1 http://wordpress.com/ By: E. Michael D. ("Mike") Scott http://prostatecancerinfolink.net/2008/08/27/cell-genesys-halts-vital-2-gvax-trial/#comment-1074 Sun, 14 Sep 2008 10:02:57 +0000 http://talkaboutprostatecancer.wordpress.com/?p=1437#comment-1074 There are many organizations attempting to develop immunotherapeutic therapies for prostate cancer, in the US and elsewhere.

The most advanced of these products is sipuleucel-T (Provenge), which could get regulatory approval as early as next year.

ClinicalTrials.gov lists more than 65 trials of “vaccines” for treatment of prostate cancer, but the vast majority of these are early stage trials of products that are unlikely to make it to the market.

]]> By: jan vanderkerken http://prostatecancerinfolink.net/2008/08/27/cell-genesys-halts-vital-2-gvax-trial/#comment-1067 Sat, 13 Sep 2008 19:28:35 +0000 http://talkaboutprostatecancer.wordpress.com/?p=1437#comment-1067 Are there any other companies performing trials with vaccines against prostate cancer?

]]>